Beranda › Glomerulosklerosis Segmental Fokal › Minnesota
Uji klinis Glomerulosklerosis Segmental Fokal di Minnesota
5 studi untuk Glomerulosklerosis Segmental Fokal mencari peserta di lokasi di Minnesota.
Kota di Minnesota
Teks studi resmi (Bahasa Inggris)
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
- InterMed Consultants - Edina Clinic- Site Number : 8400019, Edina
Menerima pesertaFase 2
Usia 16 hingga 75 · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT06500702Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- University of Minnesota, Minneapolis
Menerima peserta
Hingga usia 21 · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT02235857Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- University of Minnesota, Masonic Children's Hospital, Minneapolis
Menerima pesertaFase 2
Usia 1 hingga 17 · Semua jenis kelamin · Diperbarui 12 Mei 2026 · NCT05003986SLIT ABS: Study on Patients With Autoimmune Podocytopathy
- Mayo Clinic, Rochester
Menerima peserta
Usia 0 hingga 99 · Semua jenis kelamin · Diperbarui 8 Apr 2026 · NCT07516964A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
- University of Minnesota, Minneapolis
Menerima pesertaFase 3
Usia 12 hingga 80 · Semua jenis kelamin · Diperbarui 3 Feb 2026 · NCT05183646Dari ClinicalTrials.gov, data diambil 4 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.